Study examines whether maternal COVID-19 mRNA vaccination during pregnancy is associated with neurodevelopmental outcomes in offspring at 18–30 months of age.
Researchers are gaining a clearer picture of this patient population, noting that they have a distinct symptom profile and biomarkers that set them apart from smokers with the disease.
Study compares the effectiveness of maternal RSV vaccination versus infant nirsevimab against respiratory syncytial virus (RSV) infection and hospitalization in infants.
Study assesses whether holding certain DMARD therapy for two weeks after COVID-19 vaccination improves vaccine immunogenicity or worsens arthritis disease activity.